N-methyl-D-aspartate receptor 2B subunit (GRIN2B) gene variation is associated with alerting, but not with orienting and conflicting in the Attention Network Test

Neuropharmacology

Volumn 63, Issue 2, 2012, Pages 259-265

  Schulz, Stefanie ^a   Arning, Larissa ^a   Pinnow, Marlies ^a   Epplen, Jörg T ^a   Beste, Christian ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Alertness; Glutamate; GRIN2B; Noradrenaline; Phasic alertness

Indexed keywords

GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B;

ADULT; ALERTNESS; ALLELE; ARTICLE; ATTENTION; ATTENTION NETWORK TEST; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; GRIN2B GENE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; MALE; NERVE CELL NETWORK; NEUROMODULATION; NEUROPSYCHOLOGICAL TEST; NEUROTRANSMISSION; NORMAL HUMAN; ORIENTATION; PRIORITY JOURNAL; RESPONSE TIME; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ALLELES; AROUSAL; ATTENTION; CONFLICT (PSYCHOLOGY); CUES; FEMALE; GENOTYPE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; ORIENTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; REACTION TIME; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84861964961     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.02.024     Document Type: Article

References (89)

1. Amado, I., Lupianez, J., Chirio, M., Landgraf, S., Willard, D., 2011. Alertness can be improved by an interaction between orienting attention and alerting attention in schizophrenia. Behav. Brain Funct. 5, 7-24.
2. Arning, L., Kraus, P.-H., Valentin, S., Saft, C., Andrich, J., Epplen, J.T., 2005. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. Neurogenetics 6, 25-28.
3. Aston-Jones, G., Cohen, J.D., 2005. An integrative theory of locus coeruleusnorepinephrine function: adaptive gain and optimal performance. Annu. Rev. Neurosci. 28, 403-450.
4. Beste, C., Saft, C., Güntürkün, O., Falkenstein, M., 2008. Increased cognitive functioning in symptomatic Huntington's disease as revealed by behavioral and event-related potential indices of auditory sensory memory and attention. J. Neurosci. 28, 11695-11702.
5. Beste, C., Baune, B.T., Domschke, K., Falkenstein, M., Konrad, C., 2010. Dissociable influences of NR2B- receptor related neural transmission of functions of distinct associative basal ganglia circuits. Neuroimage 52, 309-315.
6. Beste, C., Wascher, E., Güntürkün, O., Dinse, H., 2011. Improvement and impairment of visually guided behavior through LTP- and LTD-like exposure-based visual learning. Curr. Biol. 21, 876-882.
7. Castner, S.A., Williams, G.V., 2007. Tuning the engine of cognition: a focus on NMDA/D1 receptor interactions in prefrontal cortex. Brain Cogn. 63, 94-122.
8. Charléty, P.J., Chergui, K., Akaoka, H., Saunier, C.F., Buda, M., Aston-Jones, G., Chouvet, G., 1993. Serotonin differentially modulates responses mediated by specific excitatory amino acid receptors in the rat locus coeruleus. Eur. J. Neurosci. 5, 1024-1028.
9. Cherlyn, S.Y.T., Woon, P.S., Liu, J.J., Ong, W.Y., Tsai, G.C., Sim, K., 2010. Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance. Neurosci. Biobehav. Rev. 34, 958-977.
10. Clinton, S.M., Meador-Woodruff, J.H., 2004a. Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder. Neuropsychopharmacology 29, 1353-1362.
11. Clinton, S.M., Meador-Woodruff, J.H., 2004b. Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities. Schizophr. Res. 68, 237-253.
12. Corbetta, M., Shulman, G.L., 2002. Control of goal-directed and stimulus-driven attention in the brain. Nat. Neurosci. Rev. 3, 201-215.
13. Coyle, J.T., 2006. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol. Neurobiol. 26, 365-384.
14. Cull-Candy, S., Brickley, S., Farrant, M., 2001. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 11, 327-335.
15. Daumann, J., Heekeren, K., Neukirch, A., Thiel, C.M., Möller-Hartmann, W., Gouzoulis- Mayfrank, E., 2008. Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis. Psychopharmacology (Berl.) 200, 573-583.
16. Daumann, J., Wagner, D., Heekeren, K., Neukirch, A., Thiel, C.M., 2010. Neuronal correlates of visual and auditory alertness in the DTM and ketamine model of psychosis. J. Psychopharmacol. 24, 1515-1524.
17. Davidson, M.C., Marocco, R.T., 2000. Local infusion of scopolamine into intraparietal cortex slows cover orienting in rhesus monkeys. J. Neurophysiol. 89, 1536-1549.
18. Dracheva, S., Marras, S.A.E., Elhakem, S.L., Kramer, F.R., Davis, K.L., Haroutunian, V., 2001. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am. J. Psychiatry 158, 1400-1410.
19. Fadel, J., Sarter, M., Bruno, J.P., 2001. Basal forebrain glutamatergic modulation of cortical acetylcholine release. Synapse 39, 201-212.
20. Fallgatter, A.J., Ehlis, A.-C., Herrmann, M.J., Hohoff, C., Reif, A., Freitag, C.M., et al., 2010. DTNBP1 (dysbindin) gene variants modulate prefrontal brain functions in schizophrenic patients e support for the glutamate hypothesis of schizophrenia. Genes Brain Behav. 9, 489-497.
21. Fan, J., McCandliss, B.D., Sommer, T., Raz, A., Posner, M.I., 2002. Testing the efficiency and independence of attentional networks. J. Cogn. Neurosci. 14, 340-347.
22. Fan, J., Fossella, J., Sommer, T., Wu, Y., Posner, M.I., 2003. Mapping the genetic variation of executive attention onto brain activity. Proc. Natl. Acad. Sci. U.S.A. 100, 7406-7411.
23. Fan, J., McCandliss, B.D., Fossella, J., Flombaum, J.I., Posner, M.I., 2005. The activation of attentional networks. Neuroimage 26, 471-479.
24. Fan, J., Gu, X., Guise, K.G., Liu, X., Fossella, J.,Wang, H., Posner, M.I., 2009. Testing the behavioural interaction and integration of attentional networks. Brain Cogn. 70, 209-220.
25. Fossella, J., Sommer, T., Fan, J., Wu, Y., Swanson, J.M., Pfaff, D.W., Posner, M.I., 2002. Assessing the molecular genetics of attention networks. BMC Neurosci., 3-14.
26. Goff, D.C., Coyle, J.T., 2001. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am. J. Psychiatry 158, 1367-1377.
27. Goldberg, T.E., Gold, J.M., 1995. Neurocognitive functioning in patients with schizophrenia. In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, NY, pp. 1245-1257.
28. Gooding, D.C., Braun, J.G., Studer, J.A., 2006. Attentional network task performance in patients with schizophrenia-spectrum disorders: evidence of a specific deficit. Schizophr. Res. 88, 169-178.
29. Harrsion, P.J., Weinberger, D.R., 2005. Schizophrenia genes, gene expression, and neuropathology: on the pattern of their convergence. Mol. Psychiatry 10, 40-68.
30. Hollmann, M., Heinemann, S., 1994. Cloned glutamate receptors. Annu. Rev. Neurosci. 17, 31-40.
31. Hong, C.-J., Yu, Y.W.-Y., Lin, C.-H., Cheng, C.-Y., Tsai, S.-J., 2001. Association analysis for NMDA receptor subunit 2B (GRIN2B) genetic variants and psychopathology and clozapine response in schizophrenia. Psychiatr. Genet. 11, 219-222.
32. Hunt, R., Sauna, Z.E., Ambudkar, S.V., Gottesman, M.M., Kimchi-Sarfaty, C., 2009. Silent (synonymous) SNPs: should we care about them. Methods Mol. Biol. 578, 23-39.
33. Ibrahim, H., Healy, D., Hogg, A.J., Meador-Woodruff, J., 2000a. Nucleus-specific expression of ionotropic glutamate receptor subunit mRNAs and binding sites in primate thalamus. Mol. Brain Res. 79, 1-17.
34. Ibrahim, H., Hogg, A.J., Healy, D.J., Haroutunian, V., Davis, K.L., Meador-Woodruff, J.H., 2000b. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am. J. Psychiatry 157, 1811-1823.
35. Ishikawa, M., Tanaka, C., 1977. Morphological organization of catecholamine terminals in the diencephalons of the rhesus monkey. Brain Res. 119, 43-55.
36. Javitt, D.C., 2007. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamineeglutamate interactions. Int. Rev. Neurobiol. 78, 69-108.
37. Johnson, K.A., Robertson, I.H., Barry, E., Mulligan, A., Dáibhis, A., Daly, M., et al., 2008. Impaired conflict resolution and alerting in children with ADHD: evidence from the attention network task (ANT). J. Child. Psychol. Psychiatry 49, 1339-1347.
38. Jones, B.E., 2003. Arousal systems. Front. Biosci. 8, 438-451.
39. Jones, E.G., Tighilet, B., Tran, B.V., Huntsmann, M.M., 1998. Nucleus- and cell-specific expression of NMDA and non-NMDA receptor subunits in the monkey thalamus. J. Comp. Neurol. 397, 371-393.
40. Kalia, L.V., Kalia, S.K., Salter, M.W., 2008. NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol. 7, 742-755.
41. Kang, Y.-M., Ouyang, W., Chen, J.-Y., Qiao, J.-T., Dafny, N., 2000. Norepinephrine modulates single hypothalamic arcuate neurons via α1 and β adrenergic receptors. Brain Res. 869, 146-157.
42. Khan, A.M., Stanley, B.G., Bozzetti, L., Chin, C., Stivers, C., Currás-Collazo, M.C., 2000. N-methyl-D-aspartate receptor subunit NR2B is widely expressed throughout the rat diencephalon: an immunohistochemical study. J. Comp. Neurol. 428, 428-449.
43. Kim, J.S., Kornhuber, H.H., Schmid-Burgk, W., Holmuller, B., 1980. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurisci. Lett. 20, 379-382.
44. Kiss, Tamás, Hoffmann,W.E., Scott, L., Kawabe, T.T., Milici, A.J., 2011. Role of thalamic projection in NMDA receptor-induced disruption of cortical slow oscillation and short-term plasticity. Front. Psychiatry 2, 1-12.
45. Konrad, K., Neufang, S., Thiel, C.M., Specht, K., Hanisch, C., Fan, J., et al., 2005. Development of attentional networks: an fMRI study with children and adults. Neuroimage 28, 429-439.
46. Kornhuber, J., 1990. Glutamate and schizophrenia. Trends Pharmacol. Sci. 11, 357-1357.
47. Lau, C.G., Zukin, R.S., 2007. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat. Rev. Neurosci. 8, 413-426.
48. Loftis, J.M., Janowsky, A., 2003. The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and chemical implications. Pharmacol. Ther. 97, 55-85.
49. Marocco, R.T., Davidson, M.C., 1998. Eurochemistry of attention. In: Parasuraman, R. (Ed.), The Attentive Brain. MIT Press, Cambridge, MA, pp. 35-50.
50. Marrocco, R.T., Witte, E.A., Davidson, M.C., 1994. Arousal systems. Curr. Opin. Neurobiol. 4, 166-170.
51. Marsman, A., van den Heuvel, M.P., Klomp, D.W.J., Kahn, R.S., Luijeten, P.R., Hulshoff Pol, H.E. Glutamate in schizophrenia: a focused review and meta-analysis of 1H-MRS studies. Schizophr. Bull., in press.
52. Martucci, L., Wong, A.H., de Luca, V., Likhodi, O., Wong, G.W., King, N., et al., 2006. N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: polymorphisms and mRNA levels. Schizophr. Res. 83, 214-221.
53. Matute, C., Melone, M., Vallejo-Illarramendi, A., Conti, F., 2005. Increased expression of the astrocytic glutamate transporter GLT-1 in the prefrontal cortex of schizophrenics. Glia 49, 451-455.
54. McBridge, R.L., Sutin, J., 1976. Projections of the locus coeruleus and adjacent pontine tegmentum in the cat. J. Comp. Neurol. 165, 165-184.
55. McCormick, D.A., Pape, H.C., Williamson, A., 1991. Actions of norepinephrine in the cerebral cortex and thalamus: implications for function of the central noradrenergic system. Prog. Brain Res. 88, 293-305.
56. Moghaddam, B., Adams, B., Verma, A., Daly, D., 1997. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 17, 2921-2927.
57. Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., et al., 1992. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256, 1217-1221.
58. Morgan, C.J., Mofeez, A., Brandner, B., Bromley, L., Curran, H.V., 2004. Acute effects of ketamine in memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology 29, 208-218.
59. Musso, F., Brinkmeyer, J., Ecker, D., London, M.K., Thieme, G., Warbrick, T., et al., 2011. Ketamine effects on brain functions e simultaneous fMRI/EEG during a visual oddball task. Neuroimage. doi:10.1016/j.neuroimage.2011.06.045.
60. Ness, V., Arning, L., Niesert, H.E., Stüttgen, M.C., Epplen, J.T., Beste, C., 2011. Variations in the GRIN2B gene are associated with risky decision-making. Neuropharmacology 61, 1-7.
61. Nestor, P.G., Kubicki, M., Spencer, K.M., NiznikiewiczMcCarley, R.W., Shenton, M.E., 2007. Attentional networks and cingulum bundle in chronic schizophrenia. Schizophr. Res. 90, 308-315.
62. Newcomer, J.W., Farber, N.B., Jevtovic-Todorovic, V., Selke, G., Melson, A.K., Herschey, T., et al., 1999. Ketamine-induced NMDA receptor hypofunction asa model of memory impairment and psychosis. Neuropsychopharmacology 20, 106-118.
63. Oberlin, B.G., Alford, J.L., Marocco, R.T., 2005. Normal attention orienting, but abnormal stimulus alerting and conflict effect in combined subtype of ADHD. Behav. Brain. Res. 165, 1-11.
64. Ocklenburg, S., Arning, L., Hahn, C., Gerding, W.M., Epplen, J.T., Güntürkün, O., Beste, C., 2011. Variation in the NMDA receptor 2B subunit gene GRIN2B is associated with differential language lateralization. Behav. Brain Res. 225, 284-289.
65. Oldfield, R.C., 1971. The assessment and analysis of handedness: the Edingburgh inventory. Neuropsychologia 9, 97-113.
66. Posner, M.I., 2008. Measuring alertness. Ann. N.Y. Acad. Sci. 1129, 193-199.
67. Posner, M.I., Cohen, Y., Rafal, R.D., 1982. Neural systems control of spatial orienting. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 298, 187-198.
68. Posner, M.I., Peterson, S.E., 1990. The attention systems of the human brain. Annu. Rev. Neurosci. 13, 25-42.
69. Posner, M.I., Rothbarth, M.K., 2007. Research on attention networks as a model for the integration of psychological science. Annu. Rev. Psychol. 58, 1-23.
70. Quin, S., Zao, X., Pan, Y., Liu, J., Feng, G., Fu, J., et al., 2005. An association study of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray. Eur. J. Hum. Genet. 13, 807-814.
71. Rasmusson, D.D., Clow, K., Szerb, J.C., 1994. Modification of neocortical acetylcholine release and electroencephalogram desynchronization due to brainstem stimulation by drugs applied to the basal forebrain. Neuroscience 60, 665-677.
72. Rasmusson, D.D., Szerb, J.C., Jordan, J.L., 1996. Differential effects of 6-amino-3-hydroxy-5-methyl-4- isoxazole proprionic acid and N-methyl-D-aspartate receptor antagonists applied to the basal forebrainb on cortical acetylcholine release and encephalogram desynchronization. Neuroscience 72, 419-427.
73. Reuter, M., Ott, U., Vaitl, D., Henning, J., 2007. Impaired executive control is associated with a variation in the promoter region of the tryptophan hydroxylase 2 gene. J. Cogn. Neurosci. 19, 401-408.
74. Samuels, E.R., Szabadi, E., 2008. Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation. Curr. Neuropharmacol. 6, 235-253.
75. Sarter, M., Gehring, W.J., Kozak, R., 2006. More attention must be paid: the neurobiology of attentional effort. Brain Res. Rev. 51, 145-160.
76. Seamans, J.K., Yang, C.R., 2004. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog. Neurobiol. 74, 1-58.
77. Singewald, N., Philippu, A., 1998. Release of neurotransmitters in the locus coeruleus. Prog. Neurobiol. 56, 237-267.
78. Smith, R.E., Haroutunian, V., Davis, K.L., Meador-Woodruff, J.H., 2001. Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Am. J. Psychiatry 158, 1393-1399.
79. Somogyi, J., Llewellyn-Smith, I.J., 2001. Pattern of colocalization of GABA, glutamate and glycine immunoreactivities in terminals that synapse on dendrites of noradrenergic neurons in rat locus coeruleus. Eur. J. Neurosci. 14, 219-228.
80. Sturm, W., Willmes, K., 2001. On the functional neuroanatomy of intrinsic and phasic alertness. Neuroimage 14, 76-84.
81. Talbot, K., Cho, C.S., Ong, W.Y., Benson, M.A., Han, L.Y., Kazi, H.A., 2006. Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. Hum. Mol. Genet. 15, 3041-3054.
82. Thimm, M., Kircher, T., Kellermann, T., Markov, V., Krach, S., Jansen, A., 2011. Effects of a CACNA1C genotype on attention networks in healthy individuals. Psychol. Med. 41, 1551-1561.
83. Thimm, M., Krug, A., Kellermann, T., Markov, V., Krach, S., Jansen, A., 2010. The effects of a DTNBP1 gene variant on attention networks: an fMRI study. Behav. Brain Funct. 6, 54.
84. Turchi, J., Sarter, M., 2001. Bidirectional modulation of basal forebrain N-methyl-Daspartate receptor function differentially affects visual attention but not visual discrimination performance. Neuroscience 104, 407-417.
85. Umbricht, D., Schmid, L., Koller, R., Vollenweider, F.X., Hell, D., Javitt, D., 2000. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch. Gen. Psychiatry 57, 1139-1147.
86. Urbanek, C., Weinges-Evers, N., Bellmann-Strobl, J., Bock, M., Dörr, J., Hahn, E., et al., 2010. Attention network test reveals alerting network dysfunction in multiple sclerosis. Mult. Sler. 16, 93-99.
87. Verma, A., Moghaddam, B., 1996. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J. Neurosci. 16, 373-379.
88. Wang, K., Fan, J., Dong, Y., Wang, C., Lee, T.M.C., Posner, M.I., 2005. Selective impairment of attentional networks of orienting and executive control in schizophrenia. Schizophr. Res. 78, 235-241.
89. Yanaka, H.T., Saito, D.N., Uchiyama, Y., Sadato, N., 2010. Neural substrates of phasic alertness: a functional magnetic resonance imaging study. Neurosci. Res. 68, 51-58.